A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

NCT07141004 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Psoriatic

Interventions

DRUG: Guselkumab

Sponsor

Johnson & Johnson Private Limited